Cargando…

Cardioprotection with halogenated gases: how does it occur?

Numerous studies have studied the effect of halogenated agents on the myocardium, highlighting the beneficial cardiac effect of the pharmacological mechanism (preconditioning and postconditioning) when employed before and after ischemia in patients with ischemic heart disease. Anesthetic preconditio...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358986/
https://www.ncbi.nlm.nih.gov/pubmed/28352158
http://dx.doi.org/10.2147/DDDT.S127916
_version_ 1782516325346705408
author Guerrero-Orriach, Jose Luis
Escalona Belmonte, Juan Jose
Ramirez Fernandez, Alicia
Ramirez Aliaga, Marta
Rubio Navarro, Manuel
Cruz Mañas, Jose
author_facet Guerrero-Orriach, Jose Luis
Escalona Belmonte, Juan Jose
Ramirez Fernandez, Alicia
Ramirez Aliaga, Marta
Rubio Navarro, Manuel
Cruz Mañas, Jose
author_sort Guerrero-Orriach, Jose Luis
collection PubMed
description Numerous studies have studied the effect of halogenated agents on the myocardium, highlighting the beneficial cardiac effect of the pharmacological mechanism (preconditioning and postconditioning) when employed before and after ischemia in patients with ischemic heart disease. Anesthetic preconditioning is related to the dose-dependent signal, while the degree of protection is related to the concentration of the administered drug and the duration of the administration itself. Triggers for postconditioning and preconditioning might have numerous pathways in common; mitochondrial protection and a decrease in inflammatory mediators could be the major biochemical elements. Several pathways have been identified, including attenuation of NFκB activation and reduced expression of TNFα, IL-1, intracellular adhesion molecules, eNOS, the hypercontraction reduction that follows reperfusion, and antiapoptotic activating kinases (Akt, ERK1/2). It appears that the preconditioning and postconditioning triggers have numerous similar paths. The key biochemical elements are protection of the mitochondria and reduction in inflammatory mediators, both of which are developed in various ways. We have studied this issue, and have published several articles on cardioprotection with halogenated gases. Our results confirm greater cardioprotection through myocardial preconditioning in patients anesthetized with sevoflurane compared with propofol, with decreasing levels of troponin and N-terminal brain natriuretic peptide prohormone. The difference between our studies and previous studies lies in the use of sedation with sevoflurane in the postoperative period. The results could be related to a prolonged effect, in addition to preconditioning and postconditioning, which could enhance the cardioprotective effect of sevoflurane in the postoperative period. With this review, we aim to clarify the importance of various mechanisms involved in preconditioning and postconditioning with halogenated gases, as supported by our studies.
format Online
Article
Text
id pubmed-5358986
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53589862017-03-28 Cardioprotection with halogenated gases: how does it occur? Guerrero-Orriach, Jose Luis Escalona Belmonte, Juan Jose Ramirez Fernandez, Alicia Ramirez Aliaga, Marta Rubio Navarro, Manuel Cruz Mañas, Jose Drug Des Devel Ther Review Numerous studies have studied the effect of halogenated agents on the myocardium, highlighting the beneficial cardiac effect of the pharmacological mechanism (preconditioning and postconditioning) when employed before and after ischemia in patients with ischemic heart disease. Anesthetic preconditioning is related to the dose-dependent signal, while the degree of protection is related to the concentration of the administered drug and the duration of the administration itself. Triggers for postconditioning and preconditioning might have numerous pathways in common; mitochondrial protection and a decrease in inflammatory mediators could be the major biochemical elements. Several pathways have been identified, including attenuation of NFκB activation and reduced expression of TNFα, IL-1, intracellular adhesion molecules, eNOS, the hypercontraction reduction that follows reperfusion, and antiapoptotic activating kinases (Akt, ERK1/2). It appears that the preconditioning and postconditioning triggers have numerous similar paths. The key biochemical elements are protection of the mitochondria and reduction in inflammatory mediators, both of which are developed in various ways. We have studied this issue, and have published several articles on cardioprotection with halogenated gases. Our results confirm greater cardioprotection through myocardial preconditioning in patients anesthetized with sevoflurane compared with propofol, with decreasing levels of troponin and N-terminal brain natriuretic peptide prohormone. The difference between our studies and previous studies lies in the use of sedation with sevoflurane in the postoperative period. The results could be related to a prolonged effect, in addition to preconditioning and postconditioning, which could enhance the cardioprotective effect of sevoflurane in the postoperative period. With this review, we aim to clarify the importance of various mechanisms involved in preconditioning and postconditioning with halogenated gases, as supported by our studies. Dove Medical Press 2017-03-16 /pmc/articles/PMC5358986/ /pubmed/28352158 http://dx.doi.org/10.2147/DDDT.S127916 Text en © 2017 Guerrero-Orriach et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Guerrero-Orriach, Jose Luis
Escalona Belmonte, Juan Jose
Ramirez Fernandez, Alicia
Ramirez Aliaga, Marta
Rubio Navarro, Manuel
Cruz Mañas, Jose
Cardioprotection with halogenated gases: how does it occur?
title Cardioprotection with halogenated gases: how does it occur?
title_full Cardioprotection with halogenated gases: how does it occur?
title_fullStr Cardioprotection with halogenated gases: how does it occur?
title_full_unstemmed Cardioprotection with halogenated gases: how does it occur?
title_short Cardioprotection with halogenated gases: how does it occur?
title_sort cardioprotection with halogenated gases: how does it occur?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358986/
https://www.ncbi.nlm.nih.gov/pubmed/28352158
http://dx.doi.org/10.2147/DDDT.S127916
work_keys_str_mv AT guerreroorriachjoseluis cardioprotectionwithhalogenatedgaseshowdoesitoccur
AT escalonabelmontejuanjose cardioprotectionwithhalogenatedgaseshowdoesitoccur
AT ramirezfernandezalicia cardioprotectionwithhalogenatedgaseshowdoesitoccur
AT ramirezaliagamarta cardioprotectionwithhalogenatedgaseshowdoesitoccur
AT rubionavarromanuel cardioprotectionwithhalogenatedgaseshowdoesitoccur
AT cruzmanasjose cardioprotectionwithhalogenatedgaseshowdoesitoccur